logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine(DM4) CAS 796073-69-3

N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine(DM4) CAS 796073-69-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 796073-69-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
796073-69-3
Appearance::
White To Light Yellow Solid
Molecular Formula::
C38H54ClN3O10S
Molecular Weight::
780.36700
EINECS NO::
641-067-1
MDL NO: NA:
XNA
CAS NO::
796073-69-3
Appearance::
White To Light Yellow Solid
Molecular Formula::
C38H54ClN3O10S
Molecular Weight::
780.36700
EINECS NO::
641-067-1
MDL NO: NA:
XNA
N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine(DM4) CAS 796073-69-3

Product Description:

Product Name: N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine(DM4) CAS NO: 796073-69-3

 

 

Synonyms:

Maytansine, N2'-deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-;DM4 top3;

Mertansine Impurity 1;

N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine(DM4);

 

 

Chemical & Physical Properties:

Appearance: White to light yellow solid

Assay :≥99.0%

Density: 1.29±0.1 g/cm3(Predicted)

Melting Point: 185-187 ℃ (decomp)

Boiling Point: 943.2±65.0℃(Predicted)

Pka: 9.82±0.70(Predicted)

 

 

Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs).M4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody drug conjugate.

N2''-Deacetyl-N2''-(4-mercapto-4-methyl-1-oxopentyl)-maytansine is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the targeted treatment of cancer.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.